🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Christos Vaklavas

University of Utah

ORCID: 0000-0002-9919-2748

Also affiliated with Huntsman Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
4.9Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology

Nature Cancer(2022)10.1038/s43018-022-00337-6
Top 6%
3.9DataRank
Top 6%400 citations

Maihi Fujita, Andrew Butterfield, Sandra D. Scherer, Matthew H. Bailey, Zhengtao Chu +37 more

Papers

Driven by 10 papers — median percentile 86. Top paper: “Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W”.

Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W

Journal of Clinical Oncology(2020)10.1200/jco.19.02630
N/A
4.7DataRank · unranked
179 citations

Fangxin Hong, Christos Vaklavas, Heather H. Cheng, Peter S. Hammerman, Edith P. Mitchell +17 more

A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology

Nature Cancer(2022)10.1038/s43018-022-00337-6
Top 6%
3.9DataRank
Top 6%400 citations

Maihi Fujita, Andrew Butterfield, Sandra D. Scherer, Matthew H. Bailey, Zhengtao Chu +37 more

Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Nature Medicine(2024)10.1038/s41591-024-03267-1
N/A
1.4DataRank · unranked
43 citations

Meghna S. Trivedi, Christina Yau, Rita Nanda, Hope S. Rugo, Marie Davidian +55 more

A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome

Frontiers in Immunology(2023)10.3389/fimmu.2023.1229823
Top 21%
0.944DataRank
Top 21%26 citations

Jordan P. McPherson, Magdalena Kovacsovics-Bankowski, Joanne Jeter, Christos Vaklavas, Umang Swami +10 more

Datopotamab–deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Nature Medicine(2024)10.1038/s41591-024-03266-2
N/A
0.610DataRank · unranked
13 citations

Jane Meisel, Christina Yau, Hope S. Rugo, Rita Nanda, Marie Davidian +52 more

TOWARDS Study: Patient-Derived Xenograft Engraftment Predicts Poor Survival in Patients With Newly Diagnosed Triple-Negative Breast Cancer

JCO Precision Oncology(2024)10.1200/po.23.00724
N/A
0DataRank · unranked
9 citations

Cindy Matsen, Zhengtao Chu, Kenneth M. Boucher, Sandra D. Scherer, Satya S. Pathi +15 more

Hallmarks and Determinants of Oncogenic Translation Revealed by Ribosome Profiling in Models of Breast Cancer

Translational Oncology(2020)10.1016/j.tranon.2019.12.002
N/A
0DataRank · unranked
14 citations

Scott W. Blume, William E. Grizzle, Christos Vaklavas

The association between time-of-day of habitual exercise training and changes in relevant cancer health outcomes among cancer survivors

PLoS ONE(2021)10.1371/journal.pone.0258135
N/A
0DataRank · unranked
2 citations

Mary C. Playdon, Kelly Glazer Baron, Mei Wei, Kristen Kelley, Christos Vaklavas +10 more

A breast cancer patient-derived xenograft and organoid platform for drug discovery and precision oncology

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.28.433268
N/A
0DataRank · unranked
20 citations

Maihi Fujita, Andrew Butterfield, Sandra D. Scherer, Matthew H. Bailey, Zhengtao Chu +37 more

Automated lesion detection of breast cancer in [18F] FDG PET/CT using a novel AI-Based workflow

Frontiers in Oncology(2022)10.3389/fonc.2022.1007874
N/A
0DataRank · unranked
13 citations

Steven P. Rowe, Vered Stearns, Roisín M. Connolly, Christos Vaklavas, Minetta C. Liu +5 more